Search Results: 27 vacancies
...analytic skills? If so, this is the role for you.
As a QC Associate, you will be responsible for conducting sample testing of... ...immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory...
...the Senior Superintendent/Superintendent in the management and operations of the team; may be indirectly responsible for a team of associates:
Scheduling day-to-day shopfloor activities and resources handling to ensure timely availability of test results
Reviews test...
...matrix for project team and Work Package managers in documentation associated with change control process.
Support the GSK Work Package... ...system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory...
...and calibration programs) based on risk approach.
Identify associated resources (spare parts, tools, external or internal activities,... ...immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV,...
...to cGMP and safety requirements
Ensure good housekeeping of associated production facilities so that they are kept in good operational... ...immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV,...
...You’ll also get to learn from us, develop your skills and gain valuable experience for wherever the future takes you.
With an investment of S$510 million, our state-of-the-art vaccines manufacturing facility at Tuas was opened in June 2009 by Singapore's Prime Minister...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
...You’ll also get to learn from us, develop your skills and gain valuable experience for wherever the future takes you.
With an investment of S$510 million, our state-of-the-art vaccines manufacturing facility at Tuas was opened in June 2009 by Singapore's Prime Minister...
...vision is to become the most valued and trusted medicines company in the world. How can we achieve this? With our people. It is our associates that drive us each day to reach our ambitions. Be a part of this mission and join us! Learn more here:
You’ll receive: You can find...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
...You’ll also get to learn from us, develop your skills and gain valuable experience for wherever the future takes you.
With an investment of S$510 million, our state-of-the-art vaccines manufacturing facility at Tuas was opened in June 2009 by Singapore's Prime Minister...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
...You’ll also get to learn from us, develop your skills and gain valuable experience for wherever the future takes you.
With an investment of S$510 million, our state-of-the-art vaccines manufacturing facility at Tuas was opened in June 2009 by Singapore's Prime Minister...
...You’ll also get to learn from us, develop your skills and gain valuable experience for wherever the future takes you.
With an investment of S$510 million, our state-of-the-art vaccines manufacturing facility at Tuas was opened in June 2009 by Singapore's Prime Minister...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
...You’ll also get to learn from us, develop your skills and gain valuable experience for wherever the future takes you.
With an investment of S$510 million, our state-of-the-art vaccines manufacturing facility at Tuas was opened in June 2009 by Singapore's Prime Minister...
...vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).
Our success absolutely depends...
